The Stem Cell Network is conducting an open call for Impact Research Grants in three specific areas. Impact Grants are reviewed every three months; deadlines for application are indicated in the application guidelines.
Competition now open: (Upcoming deadline: April 3, 2014). Total SCN funds that may be requested for a Clinical Translation Impact or Commercialization Impact grant is $100,000 per award. Total SCN funds that may be requested for a SCN Public Policy Impact grant is $50,000 per award..
Clinical Translation Impact Grants are aimed at projects that develop novel cellular or therapeutics stem cell approaches to tissue repair and regeneration within specific disease models. Proposals must clearly identify the translational “bench to bedside” path of the research and where the proposed research stands along the path. Projects that principally involve basic research are not encouraged. Projects that may be funded within this program can involve:
- The completion of proof-of-principle experiments in small or large animal models using novel cells or compounds/drugs or using novel transplantation approaches;
- The identification/characterization of compounds/drugs that target stem cell differentiation/proliferation with the aim to develop novel therapeutic approaches;
- The production of reagents necessary for the completion of a clinical trials
In all cases, projects must be clearly aimed at developing therapies and therefore must outline a clear path to the clinic. Partnerships with health charities, non-federal government organizations or industry are a necessary component of the project.
Please review the Clinical Translation Impact Grant guidelines for full details on the program. Total SCN funds that may be requested for a SCN Clinical Translation Impact is $100,000 for the period of July 1, 2014 - March 31, 2015
Commercialization Impact Grants are aimed at projects that generate novel technologies and intellectual property (IP) which have commercial value in the stem cell research or therapeutics markets. It complements the existing IP Protection Fund which provides funds for filing provisional patent applications to protect IP that has been developed through SCN-funded research. The Commercialization Impact Program supports projects under two categories:
Category 1: The development of stem cell-related products or services for the research market to the point where they will be ready for commercial license with an industry partner at the completion of the one-year term of the project. The application must set out a coherent product research and development plan and be accompanied by a strong letter of support from an industry partner.
Category 2: The generation of data to support the further development of IP between the filing of a provisional patent application and first filing of the complete patent application. Although a letter of support from an industry partner is not mandatory for this category, it would strengthen the application.
Please review the Commercialization Impact Grant guidelines for full details on the program. Total SCN funds that may be requested for a SCN Commercialization Impact is $100,000 for the period of July 1, 2014 - March 31, 2015.
Public Policy Impact Grants are aimed at projects that will address public policy issues relevant to stem cell research. While projects are not required to form partnerships with industry, proposals must include specific plans to engage receptors such as basic scientists, policy makers or the public as part of their research approach, as well as engage the international community.
Please review the Public Policy Impact Grant guidelines for full details on the program. Total SCN funds that may be requested for a SCN Public Policy Impact is $50,000 for the period of July 1, 2014 - March 31, 2015.